OncoGenex Pharmaceuticals CEO Richard Stewart's 2018 pay jumps 423% to $1.1M
OncoGenex Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: March 28, 2019
OncoGenex Pharmaceuticals reported fiscal year 2018 executive compensation information on March 28, 2019.
In 2018, four executives at OncoGenex Pharmaceuticals received on average a compensation package of $805K, a 35% increase compared to previous year.
Average pay of disclosed executives at OncoGenex Pharmaceuticals
Richard Stewart, Chief Executive Officer, received $1.1M in total, which increased by 423% compared to 2017. 46% of Stewart's compensation, or $500K, was in salary. Stewart also received $273K in non-equity incentive plan and $318K in option awards.
Anthony Clarke, Chief Scientific Officer, received a compensation package of $722K, which increased by 313% compared to previous year. 58% of the compensation package, or $420K, was in salary.
Cindy Jacobs, Chief Medical Officer, earned $712K in 2018, a 38% decrease compared to previous year.
John Bencich, Chief Financial Officer, received $695K in 2018, which decreases by 39% compared to 2017.
Related executives
You may also like
Source: SEC filing on March 28, 2019.